These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32036397)

  • 1. Laser enucleation of the prostate versus transurethral resection of the prostate: perioperative outcomes from the ACS NSQIP database.
    Heidar NA; Labban M; Misrai V; Mailhac A; Tamim H; El-Hajj A
    World J Urol; 2020 Nov; 38(11):2891-2897. PubMed ID: 32036397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and Perioperative Outcomes Across Major Benign Prostatic Hyperplasia Procedures from the ACS-NSQIP 2011-2015.
    Anderson BB; Heiman J; Large T; Lingeman J; Krambeck A
    J Endourol; 2019 Jan; 33(1):62-68. PubMed ID: 30039715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity and mortality after benign prostatic hyperplasia surgery: data from the American College of Surgeons national surgical quality improvement program.
    Bhojani N; Gandaglia G; Sood A; Rai A; Pucheril D; Chang SL; Karakiewicz PI; Menon M; Olugbade K; Ruhotina N; Sammon JD; Sukumar S; Sun M; Ghani KR; Schmid M; Varda B; Kibel AS; Zorn KC; Trinh QD
    J Endourol; 2014 Jul; 28(7):831-40. PubMed ID: 24517323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update.
    Cornu JN; Ahyai S; Bachmann A; de la Rosette J; Gilling P; Gratzke C; McVary K; Novara G; Woo H; Madersbacher S
    Eur Urol; 2015 Jun; 67(6):1066-1096. PubMed ID: 24972732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia.
    Cowles RS; Kabalin JN; Childs S; Lepor H; Dixon C; Stein B; Zabbo A
    Urology; 1995 Aug; 46(2):155-60. PubMed ID: 7542818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of outcomes after TURP versus photoselective vaporization of the prostate with respect to trainee involvement utilizing ACS NSQIP.
    Olcese SP; Derosa R; Kern SQ; Lustik MB; Sterbis JR; McMann LP
    Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):227-32. PubMed ID: 24732080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of transurethral enucleation of the prostate using the 120-W thulium Laser (Vela™ XL) compared to bipolar transurethral resection of the prostate (TURP) in aging male.
    Hou CP; Lin YH; Juang HH; Chang PL; Chen CL; Yang PS; Tsui KH
    Aging (Albany NY); 2020 Jan; 12(2):1888-1898. PubMed ID: 31991402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012.
    Thangasamy IA; Chalasani V; Bachmann A; Woo HH
    Eur Urol; 2012 Aug; 62(2):315-23. PubMed ID: 22575913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the 5-item Frailty Index predict surgical complications of endoscopic surgical management for benign prostatic obstruction? An analysis of the ACS-NSQIP.
    Labban M; Frego N; Qian Z; Nguyen DD; Chen CR; Berk BD; Lipsitz SR; Bhojani N; Kathrins M; Trinh QD
    World J Urol; 2022 Nov; 40(11):2649-2656. PubMed ID: 36125504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of benign prostate hyperplasia in Nigeria: open prostatectomy versus transurethral resection of the prostate.
    Ofoha CG; Raphael JE; Dakum NK; Shu'aibu SI; Akhaine J; Yaki IM
    Pan Afr Med J; 2021; 39():165. PubMed ID: 34539961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
    Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
    Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Modification of Transurethral Enucleation and Resection of the Prostate in Patients With Prostate Glands Larger than 80 mL: Surgical Procedures and Clinical Outcomes.
    Li K; Wang D; Hu C; Mao Y; Li M; Si-Tu J; Huang W; Qiu W; Qiu J
    Urology; 2018 Mar; 113():153-159. PubMed ID: 29203184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised controlled trial to determine the clinical and cost effectiveness of thulium laser transurethral vaporesection of the prostate (ThuVARP) versus transurethral resection of the prostate (TURP) in the National Health Service (NHS) - the UNBLOCS trial: a study protocol for a randomised controlled trial.
    Worthington J; Taylor H; Abrams P; Brookes ST; Cotterill N; Noble SM; Page T; Swami KS; Lane JA; Hashim H
    Trials; 2017 Apr; 18(1):179. PubMed ID: 28412960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity and mortality after surgery for lower urinary tract symptoms: a study of 95 577 cases from a nationwide German health insurance database.
    Gilfrich C; Leicht H; Fahlenbrach C; Jeschke E; Popken G; Stolzenburg JU; Weißbach L; Zastrow C; Günster C
    Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):406-411. PubMed ID: 27502738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Holmium Laser enucleation of the prostate (HoLEP) versus Transurethral Resection of the Prostate (TURP).
    Barboza LE; Malafaia O; Slongo LE; Meyer F; Nassif PA; Tabushi FI; Wendler E; Beraldi RA
    Rev Col Bras Cir; 2015 Jun; 42(3):165-70. PubMed ID: 26291257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Evaluation of 1470 nm Diode Laser Enucleation
    Ionson A; Monfared SHB; Ursiny M; Katz M; Wang D; Babayan R; Wason S
    J Endourol; 2021 Aug; 35(8):1204-1210. PubMed ID: 33499745
    [No Abstract]   [Full Text] [Related]  

  • 19. Early outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate.
    Palaniappan S; Kuo TL; Cheng CW; Foo KT
    Singapore Med J; 2016 Dec; 57(12):676-680. PubMed ID: 26875682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monopolar enucleation versus transurethral resection of the prostate for small- and medium-sized (< 80 cc) benign prostate hyperplasia: a prospective analysis.
    Enikeev D; Rapoport L; Gazimiev M; Allenov S; Inoyatov J; Taratkin M; Laukhtina E; Sung JM; Okhunov Z; Glybochko P
    World J Urol; 2020 Jan; 38(1):167-173. PubMed ID: 30963229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.